Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOLEDO: Apomorphine Infusion in Parkinson's Disease
NCT02006121Phase 3Completed
- Sponsor
- Britannia Pharmaceuticals
- Start
- Mar 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of apomorphine in Parkinson's disease (PD), sponsored by Britannia Pharmaceuticals. Started Mar 2014; status: completed.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02006121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02006121.